(NYSE: BHC) Bausch Health Companies's forecast annual revenue growth rate of 2.32% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.24%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.32%.
Bausch Health Companies's revenue in 2025 is $9,731,000,000.On average, 4 Wall Street analysts forecast BHC's revenue for 2025 to be $3,692,156,431,722, with the lowest BHC revenue forecast at $3,679,240,656,216, and the highest BHC revenue forecast at $3,710,135,043,406. On average, 4 Wall Street analysts forecast BHC's revenue for 2026 to be $3,799,760,178,013, with the lowest BHC revenue forecast at $3,753,520,223,502, and the highest BHC revenue forecast at $3,851,118,401,215.
In 2027, BHC is forecast to generate $3,840,708,175,292 in revenue, with the lowest revenue forecast at $3,755,737,524,018 and the highest revenue forecast at $3,954,075,055,174.